FI941117A0 - Benzylimidazopyridine derivatives as angiotensin II receptor antagonists - Google Patents

Benzylimidazopyridine derivatives as angiotensin II receptor antagonists

Info

Publication number
FI941117A0
FI941117A0 FI941117A FI941117A FI941117A0 FI 941117 A0 FI941117 A0 FI 941117A0 FI 941117 A FI941117 A FI 941117A FI 941117 A FI941117 A FI 941117A FI 941117 A0 FI941117 A0 FI 941117A0
Authority
FI
Finland
Prior art keywords
benzylimidazopyridine
angiotensin
derivatives
receptor antagonists
antagonists
Prior art date
Application number
FI941117A
Other languages
Finnish (fi)
Swedish (sv)
Other versions
FI941117A (en
Inventor
Silva Jardine Paul A Da
Ronald T Wester
Philip A Carpino
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of FI941117A0 publication Critical patent/FI941117A0/en
Publication of FI941117A publication Critical patent/FI941117A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Ophthalmology & Optometry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
FI941117A 1993-03-10 1994-03-09 Benzylimidazopyridine derivatives as angiotensin II receptor antagonists FI941117A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US4395893A 1993-03-10 1993-03-10

Publications (2)

Publication Number Publication Date
FI941117A0 true FI941117A0 (en) 1994-03-09
FI941117A FI941117A (en) 1994-09-11

Family

ID=21929806

Family Applications (1)

Application Number Title Priority Date Filing Date
FI941117A FI941117A (en) 1993-03-10 1994-03-09 Benzylimidazopyridine derivatives as angiotensin II receptor antagonists

Country Status (7)

Country Link
EP (1) EP0690859A1 (en)
JP (1) JPH08502757A (en)
AU (1) AU6297494A (en)
CA (1) CA2157037A1 (en)
FI (1) FI941117A (en)
IL (1) IL108842A0 (en)
WO (1) WO1994020499A1 (en)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4200954A1 (en) * 1991-04-26 1992-10-29 Bayer Ag New heterocycle-substd. phenylacetic acid derivs. - are angiotensin II antagonists for treating arterial hypertonia, atherosclerosis, coronary insufficiency, ischaemic cerebral disorders, respiratory disorders, etc.

Also Published As

Publication number Publication date
IL108842A0 (en) 1994-06-24
JPH08502757A (en) 1996-03-26
AU6297494A (en) 1994-09-26
EP0690859A1 (en) 1996-01-10
WO1994020499A1 (en) 1994-09-15
FI941117A (en) 1994-09-11
CA2157037A1 (en) 1994-09-15

Similar Documents

Publication Publication Date Title
NO985225L (en) Indole derivatives useful as endothelin receptor antagonists
NO972016D0 (en) Indolyl-Y receptor antagonists
DE69734833D1 (en) VITRONEKTIN RECEPTOR ANTAGONISTS
DE69812096D1 (en) NEUROPEPTID Y RECEPTOR ANTAGONISTS
DK0630376T3 (en) Condensed indole derivatives as 5-HT4 receptor antagonists
NO965036D0 (en) Quinoline derivatives such as techykinin NK3 receptor antagonists
NO981477L (en) Pyrimidine derivatives as 5HT2C receptor antagonists
DK0569013T3 (en) Quinoline Compounds as Angiotensin II Antagonists
ID16742A (en) ENDOTELIN RECEPTOR ANTAGONISTS
FI961628A0 (en) Indole derivatives as NMDA antagonists
NO974043L (en) Indole derivatives as EAA antagonists
ID24726A (en) TROMBIN RECEPTOR ANTAGONISTS
KR960700722A (en) Fibrinogen receptor antagonists
ID24162A (en) VITRONECTTIN RECEPTOR ANTAGONISTS
DK0906294T3 (en) Benzoxazinone-dopamine D4 receptor antagonists
FI951798A0 (en) Bentzofuran derivatives as 5-HT1-like receptor antagonists
NO985970D0 (en) Indoline derivatives useful as 5_HT-2C receptor antagonists
NO961333D0 (en) Novel pyrazole derivatives as angiotensin II antagonists
NO972612D0 (en) Pyridazones as endothelin receptor antagonists
FI943359A (en) Azacyclic-heterocyclic compounds as angiotensin II receptor antagonists
NO985972L (en) Indoline derivatives useful as 5-HT-2C receptor antagonists
NO950684D0 (en) Novel imidazopyridine derivatives as angiotensin II antagonists
NO974205D0 (en) Heterocyclic-substituted piperazine derivatives as tachykinin receptor antagonists
FI941118A0 (en) Benzylimidazopyridine derivative as angiotensin II receptor antagonist
DE69617010D1 (en) ISAZOLE DERIVATIVES AS FIBRINOGEN RECEPTOR ANTAGONISTS